The difficult diagnosis of pulmonary vascular disease in heart failure

Galiè Nazzareno, Manes Alessandra, Palazzini Massimiliano

Source: Eur Respir J 2016; 48: 311-314
Journal Issue: August
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Galiè Nazzareno, Manes Alessandra, Palazzini Massimiliano. The difficult diagnosis of pulmonary vascular disease in heart failure. Eur Respir J 2016; 48: 311-314

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009



Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 422-430
Year: 2015



Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010

Echocardiography for the diagnosis of pulmonary vascular disease
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016


Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010



Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019

How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016


Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 472
Year: 2011


Evaluation of pulmonary functions in valvular heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002

Unrecognized low-flow congenital heart disease or relapse of pulmonary tuberculosis?
Source: Eur Respir J 2005; 26: Suppl. 49, 657s
Year: 2005

Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017
Year: 2018



The heart rate variability in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008


Hemodynamic assessment of pulmonary hypertension in grown-up congenital heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Cardiovascular diseases: congenital, cardiogenic pulmonary oedema, mitral stenosis, chronic heart failure and myocardial infarction
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=290
Year: 2005